The CAPN3 p.Lys 254del variant is not always associated with dominant CAPN3-related muscular dystrophy

dc.contributor.authorValls, Andrea
dc.contributor.authorGutiérrez Gutiérrez, Gerardo
dc.contributor.authorMartínez, Agustín
dc.contributor.authorRuiz Roldán, Cristina
dc.contributor.authorCamaño, Pilar
dc.contributor.authorLópez de Munain, Adolfo
dc.contributor.authorSáenz, Amets
dc.date.accessioned2024-07-15T12:53:17Z
dc.date.available2024-07-15T12:53:17Z
dc.date.issued2024
dc.description.abstractIntroduction/Aims Limb-girdle muscular dystrophy R1 (LGMDR1) calpain 3-related usually presents as a recessively transmitted weakness of proximal limb-girdle muscles due to pathogenic variants in the CAPN3 gene. Pathogenic variants in this gene have also been found in patients with an autosomal dominantly inherited transmission pattern (LGMDD4). The mechanism underlying this difference in transmission patterns has not yet been elucidated. Camptocormia, progressive limb weakness, myalgia, back pain, and increased CK levels are common clinical features associated with dominant forms. The p.Lys254del pathogenic variant was associated with camptocormia in two LGMDD4 families. This study aimed to present carriers found in recessively transmitted LGMDR1 families bearing the p.Lys254del variant that do not show muscle weakness. Methods DNA sequencing was performed on exon 5 of CAPN3 in family members to establish the carrier status of the pathogenic variant. They were evaluated clinically and MRI was performed when available. Results Two families presented with the p.Lys254del pathogenic variant in a homozygous or compound heterozygous state. Family members carrying only the pathogenic variant in the heterozygous state did not demonstrate the myopathic characteristics described in dominant patients. Camptocormia and other severe clinical symptoms were not observed. Discussion We conclude that the p.Lys254del pathogenic variant per se cannot be solely responsible for camptocormia in dominant patients. Other undisclosed factors may regulate the phenotype associated with the dominant inheritance pattern in CAPN3 pathogenic variant carriers.eng
dc.description.filiationUEMspa
dc.description.impact2.8 Q2 JCR 2023spa
dc.description.impact0.964 Q2 SJR 2023spa
dc.description.impactNo data IDR 2023eng
dc.description.sponsorshipPI21/00047spa
dc.description.sponsorshipGovernment of the Basque Country, Grant/Award Number: 2021111022eng
dc.description.sponsorshipCB06/05/1126eng
dc.identifier.citationValls, A., Gutiérrez‐Gutiérrez, G., Martínez, A., Ruiz‐Roldán, C., Camaño, P., López De Munain, A., & Sáenz, A. (2024). The CAPN3 p.Lys 254del variant is not always associated with dominant CAPN3 ‐related muscular dystrophy. Muscle & Nerve, 472- 476. https://doi.org/10.1002/mus.28045eng
dc.identifier.doi10.1002/mus.28045
dc.identifier.issn0148-639X
dc.identifier.issn1097-4598
dc.identifier.urihttp://hdl.handle.net/11268/12954
dc.language.isoengspa
dc.peerreviewedSispa
dc.relation.publisherversionhttps://onlinelibrary.wiley.com/doi/10.1002/mus.28045spa
dc.rights.accessRightsopen accessspa
dc.subject.otherDistrofia muscularspa
dc.subject.otherCalpaínaspa
dc.subject.otherNeurologíaspa
dc.subject.sdgGoal 3: Ensure healthy lives and promote well-being for all at all ages
dc.subject.unescoNeurologíaspa
dc.subject.unescoActividad científicaspa
dc.titleThe CAPN3 p.Lys 254del variant is not always associated with dominant CAPN3-related muscular dystrophyspa
dc.typejournal articlespa
dspace.entity.typePublication
relation.isAuthorOfPublicationb7557616-3760-45a7-a37d-86eb9a29e434
relation.isAuthorOfPublication.latestForDiscoveryb7557616-3760-45a7-a37d-86eb9a29e434

Files